期刊文献+

多普勒导丝对腺苷预处理保护冠状动脉微循环功能的评价 被引量:9

Assessing the protective effect of adenosine preconditioning on coronary microcirculation function by intracoronary Doppler guidewire
原文传递
导出
摘要 目的 :观察腺苷预处理 (APC)对缺血心肌相关冠状动脉 (冠脉 )微循环功能的保护作用。方法 :将建立心肌缺血模型的 12只中国小型家猪随机分为两组 :对照组 6只 ,仅制备心肌缺血模型 ;APC组 6只 ,制备模型前经冠脉注入腺苷 6mg。应用冠脉内多普勒导丝观察模型相关冠脉平均峰值流速 (APV)、舒张收缩流速比值(DSVR)、冠脉血流储备 (CFR)的变化。结果 :两组模型冠脉狭窄后 10min时APV、DSVR、CFR均较基础状态时明显下降 (P <0 .0 5或 <0 .0 1) ,APV、DSVR在随后实验过程中无明显变化 ;30min时两组CFR均有进一步降低趋势 (P >0 .0 5 ) ;6 0min时对照组CFR较 30min时明显降低〔(0 .96± 0 .2 7)∶(1.74± 0 .4 9) ,P <0 .0 5〕 ,而APC组CFR与 30min时相比差异无统计学意义〔(1.6 4± 0 .30 )∶(1.79± 0 .38) ,P >0 .0 5〕 ;但 12 0min时APC组CFR较前明显下降〔(0 .94± 0 .31)∶(1.6 4± 0 .30 ) ,P <0 .0 1〕 ,与同时间点对照组相比差异无统计学意义。结论 :心肌缺血模型相关冠脉在急性重度狭窄 6 0min时发生微循环功能障碍 ,APC对冠脉微循环功能具有保护作用 ,但持续时间较短。 Objective:To investigate the protective effect of adenosine preconditioning (APC) on coronary microcirculation function after myocardial ischemia.Method:Twelve little domestic Chinese pigs were established to the model of myocardial ischemia by interventional method (closed-chest) and divided into 2 groups at random: thecontrol group (CON group, n=6) and adenosine preconditioning group (APC group, n=6). APC was elicited by intracoronary infusion of adenosine before the establishment of model. Intracoronary Doppler guidewire was used to measure average peak velocity (APV) , diastolic systolic velocity ratio (DSVR) and coronary flow reserve (CFR) of the distal to the stenosis at the baseline and 10 min, 30 min, 60 min, 120 min after coronary stenosis.Result:APV, DSVR and CFR all decreased significantly in both groups (P< 0.01 or P< 0.05) after coronary stenosis, while APV, DSVR did not change obviously at the rest time. At 30 min after coronary stenosis CFR of the two groups tended to decrease (P> 0.05). At 60 min CFR of the CON group decreased significantly than that before 〔( 0.96± 0.27) vs ( 1.74± 0.49),P< 0.05〕, while CFR of the APC group didn't change obviously 〔( 1.64± 0.30) vs ( 1.79± 0.38), P> 0.05〕. At 120 min CFR of APC group decreased significantly than that before 〔( 0.94± 0.31) vs ( 1.64± 0.30),P< 0.01〕, there was no significant difference between two groups.Conclusion:The coronary microcirculation dysfunction was happened at the time point of 60 min after severe coronary stenosis, APC can protect the coronary microcirculation function, but the lasting time was short.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2004年第6期357-360,共4页 Journal of Clinical Cardiology
基金 江苏省社会发展基金资助 (No :BS2 0 0 2 0 0 9)
关键词 冠状动脉循环 腺苷 缺血预处理 心肌缺血 Coronary microcirculation Adenosine Ischemic preconditioning Myocardial ischemia
  • 相关文献

参考文献10

  • 1[1]Panza J A, Dilsizian V, Curiel R V, et al. Myocardial blood flow at rest and contractile reserve in patients with chronic coronary artery disease and left ventricular dysfunction. J Nucl Cardiol, 1999, 6:487-494.
  • 2[2]Derek M, Gary F, Mark S, et al. Ischemic preconditioning: present position and future directions. Cardiovasc Res, 1998, 37:21-33.
  • 3[3]Jong J, Jonge R, Keijzer E, et al. The role of adenosine in preconditioning. Pharmacol Ther, 2000, 87:141-149.
  • 4[4]Kloner R A, Bolli R, Mardan E, et al. Medical and cellular implications of stunning, hibernation, and ischemic preconditioning. An NHLBI workshop. Circulation, 1998, 97:1848-1867.
  • 5[5]McCully J D, Uematsu M, Parker R A, et al. Adenosine-enhanced ischemic preconditioning provides enhanced postischemic recovery and limitation of infarct size in the rabbit heart. J Thorac Cardiovasc Surg, 1998, 116:154-162.
  • 6[6]Higano S T, Lerman A, Garrat K N, et al. Assessing coronary flow physiology with intracoronary Doppler following coronary intervention. Interven Cardiol, 1996, 9:163-173.
  • 7[7]Wei K, Ragosita M, Thorpe J, et al. Noninvasive quantification of coronary blood flow reserve in humans using myocardial contrast echocardigraph. Circulation, 2001, 103:2560-2565.
  • 8[8]White C W. Clinical applications of Doppler coronary flow reserve measurement. Am J Cardiol, 1993, 71:10D-16D.
  • 9[9]Yao S K, Ober J C, Gonenne A, et al. Active oxygen species play a role in mediating platelet aggregation and cyclic flow variations in severely stenosed and endothelium-injured coronary arteries. Circ Res, 1993, 73:952-956.
  • 10沈成兴,葛均波.冠状动脉微栓塞的临床意义[J].中华心血管病杂志,2002,30(11):698-701. 被引量:21

二级参考文献11

  • 1Raimund Erbel MD, FACC, FESC,Gerd Heusch.Coronary Microembolization—Its Role in acute coronary syndromes and interventions[J].Herz.1999(7)
  • 2Ge J,Qian J,Haude M,et al.Coronary and myocardial perfusion mismatch in patients with acute coronary syndromes[].European Heart Journal.1999
  • 3Mahaffey KW,Puma JA,Babagelata A.Adenosine as an ajunct to thrombolytic therapy for myocardial infarction: results of a muticenter,randomized, placebo controlled trial-the Acute Myocardial Infarction Study of Adenosine(AMISTAD)trial[].Journal of the American College of Cardiology.1999
  • 4de Lemos JA,Antman EM,Braunwald E,et al.Abciximab improves both epicardial flow and myocardial reperfusion in ST-elevation myocardial infarction.Observations from the T1M1 14 trial[].Circulation.2000
  • 5Herrmann J,Haude M,Ge J,et al.Abnomal coronary flow velocity reserve after coronary intervention is associated with cardiac marker elevation[].Circulation.2001
  • 6Topol EJ,Leya F,Pinkerton CA,et al.For the CAVEAT Study Group.A comparison of coronary angioplasty with directional atherectomy in patients with coronary artery disease[].The New England Journal of Medicine.1993
  • 7Ito H,Taniyama Y,Iwakura K,et al.Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with reperfused anterior wall myocardial infarction[].Journal of the American College of Cardiology.1999
  • 8Mak KH,Challapalli R,Eisenberg MJ,et al.For the EPIC Investigators.Effect of platelet glycoprotein Hb/Ⅲa receptor inhibition on distal embolization during percutaneous revascularization of aorto coronary saphenous vein grafts[].The American Journal of Cardiology.1997
  • 9Hamm CW,Heeschen C,Goidmann BU,et al.Benefit of Tirofiban in high-risk patients with unstable angina identified by troponins in the PRISM Trial[].Circulation.1999
  • 10Porter TR,Li S,Oster R,et al.The clinical implications of no reflow demonstrated with intravenous perfluorocarbon containing microbubbles following restoration of Thrombolysis In Myocardial Infarction (TIMI) 3 flow in patients with acute myocardial infarction[].The American Journal of Cardiology.1998

共引文献20

同被引文献31

  • 1卢英民,韩冰,张焱,石一夫.马来酸桂哌齐特对急性心肌梗死伴充血性心力衰竭患者的血流动力学效应[J].临床心血管病杂志,2005,21(7):403-404. 被引量:13
  • 2无.慢性稳定性心绞痛诊断与治疗指南[J].中华心血管病杂志,2007,35(3):195-206. 被引量:2082
  • 3陈达,王绍久,李莹洁.马来酸桂哌齐特治疗稳定型心绞痛的临床观察[J].山西医药杂志,2007,36(6):556-557. 被引量:5
  • 4张丽 黄道飞.心脑血管病新药马来酸桂哌齐特药理及临床综述[J].中国临床医药研究杂志,2002,76:7002-7002.
  • 5Gronstein BN. Adenosine, enendogenous ant inflammatory agent [J]. JAPPL Phhysilol, 1999,96(8):5-10.
  • 6Gu D,Reynolds K,Wu X,et al.Prevalence,awareness,treatment,and control of hypertension in China[J].Hypertension,2002,40(6):920-927.
  • 7胡大一,周玉杰.Topol心血管病学[M].3版.北京:人民卫生出版社,2009:249.
  • 8Wang QD,Pernow J,Sj(o)quist PD,et al.Pharmacological possibilities for protection against myocardial reperfusion injury[J].Cardiovasc Res,2002,55(1):25-37.
  • 9Stadler B,Phillips J,Toyada Y,et al.Adenosine-enhanced ischemic preconditioning modulates necrosis and apoptosis:esffects of stunning and ischemia-reperfusion[J].Ann Thorac Surg,2001,72(2):555-563.
  • 10Jordan JE, Zhao Z, Sato H, et al. Agents to improvecardiovaseular circulation and cardiac metabolismcinepazide [ J ]. Circulation, 1995,92( Suppl I) :524.

引证文献9

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部